Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Liver Transplantation
53%
Hepatitis C Virus
40%
Liver
31%
Cirrhosis
27%
Fibrosis
25%
Hepatitis C
24%
Hepatic Stellate Cells
23%
HIV-infected Patients
21%
Liver Disease
19%
Liver Fibrosis
19%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Tumor
17%
Nonalcoholic Steatohepatitis
16%
Hepatic Fibrosis
16%
Hepatic Stellate Cell Activation
16%
Ribavirin
15%
Chronic Hepatitis C
15%
United States
14%
AIDS/HIV
13%
Liver Cancer
12%
Chronic Liver Disease
12%
Sustained Virological Response
11%
Advanced Hepatocellular Carcinoma
11%
Sorafenib
11%
Antifibrotic
10%
Hepatitis C Virus Infection
10%
Transplantation
10%
Hepatitis B Virus
10%
Hepatocytes
10%
Liver Injury
10%
Liver Transplant Recipients
10%
95% Confidence Interval
9%
Hepatitis B
9%
Liver Biopsy
9%
Primary Biliary Cirrhosis
9%
Alcoholic Hepatitis
9%
Stellate Cells
9%
Risk Factors
8%
Post-liver Transplant
8%
Direct-acting Antivirals
8%
Resection
8%
Fibrogenic
8%
Antiretroviral Therapy
8%
Clinical Trials
8%
Sofosbuvir
7%
Pegylated Interferon
7%
Drug-induced Liver Injury
7%
Interferon-α (IFN-α)
7%
Fibrogenesis
7%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
7%
Alpha-fetoprotein
6%
Chronic Hepatitis B
6%
Placebo
6%
Hazard Ratio
6%
Transforming Growth Factor-β
6%
Intrahepatic Cholangiocarcinoma (iCCA)
6%
COVID-19
6%
Hepatitis C Virus Genotypes
6%
Metabolic Dysfunction-associated Steatohepatitis
5%
Extracellular Matrix
5%
Overall Survival
5%
Response Rate
5%
Gene Signature
5%
During Pregnancy
5%
Meta-analysis
5%
Immune Checkpoint Inhibitors
5%
Kidney Transplant Recipients
5%
Immunosuppression
5%
Inflammation
5%
Apoptosis
5%
Hepatitis C Treatment
5%
Pretransplant
5%
Liver Resection
5%
Medicine and Dentistry
Hepatocellular Carcinoma
90%
Liver Transplantation
53%
Liver Disease
25%
Fibrosis
22%
Diseases
21%
Liver Cirrhosis
20%
Liver Graft
19%
Liver Fibrosis
18%
Nonalcoholic Fatty Liver
16%
Hepatitis C
14%
Liver Cancer
14%
Hepatitis C Virus
13%
Neoplasm
13%
Tumor
13%
Human Immunodeficiency Virus
13%
Malignant Neoplasm
13%
Hepatic Stellate Cell
12%
Recurrent Disease
11%
Liver Injury
11%
Hepatectomy
9%
Cholangiocarcinoma
9%
Chronic Liver Disease
8%
Genetics
8%
Fibrogenesis
8%
Living Donors
8%
Hepatitis B Virus
7%
Infection
7%
Liver Biopsy
7%
Biological Marker
7%
Alcohol Liver Disease
7%
Clinical Trial
6%
Sorafenib
6%
Fatty Liver
6%
Magnetic Resonance Imaging
5%
Stellate Cell
5%
Hepatitis B
5%
Allograft
5%
Overall Survival
5%
Pathogenesis
5%
Hazard Ratio
5%
Hepatocyte
5%
Portal Hypertension
5%
Toxic Hepatitis
5%
COVID-19
5%
Primary Biliary Cirrhosis
5%
Biopsy Technique
5%
Immunosuppressive Treatment
5%
Milan Criteria
5%
Inflammation
5%
Hepatitis
5%
Morbidity
5%
Etiology
5%
Immunotherapy
5%
Prevalence
5%
Cancer
5%
Hepatology
5%
Cell Activation
5%